Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Australia
University of Sunshine Coast, South Bank, Brisbane Emeritus Research, Camberwell Momentum Clinical Research, Darlinghurst Veritus Research, Melbourne University of the Sunshine Coast, Morayfield University of the Sunshine Coast, Sippy Downs, Sippy Downs